Trial
NCT04516941
CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Insel Gruppe AG, University Hospital Bern
Collaborators
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Condition
SARS-CoV Infection
Intervention
Edoxaban Tablets
Why stopped
Insufficient rate of patient accrual and newly available scientific evidence
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-09-08